Literature DB >> 24473421

MELAS, an important consideration in the adult population presenting with unusual and recurrent stroke-like episodes.

Alison Corr1, Maria Gaughan, Joan Moroney, Seamus Looby.   

Abstract

A 48-year-old man was admitted for workup of stroke-like symptoms and generalised tonic-clonic seizures. History and examination revealed that the patient had background diagnoses of type 2 diabetes mellitus, epilepsy and had suffered a temporal lobe infarct 3 years ago. The unusual presentation and physical findings, along with subsequent MRI findings led to a diagnosis of mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). MELAS is a mitochondrial disorder typified by the aforementioned symptoms, and is typically diagnosed in the first two decades of life.

Entities:  

Mesh:

Year:  2014        PMID: 24473421      PMCID: PMC3912399          DOI: 10.1136/bcr-2013-201640

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  8 in total

1.  MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission.

Authors:  P Montagna; R Gallassi; R Medori; E Govoni; M Zeviani; S Di Mauro; E Lugaresi; F Andermann
Journal:  Neurology       Date:  1988-05       Impact factor: 9.910

2.  Apparent diffusion coefficients of metabolites in patients with MELAS using diffusion-weighted MR spectroscopy.

Authors:  Z Liu; D Zheng; X Wang; J Zhang; S Xie; J Xiao; X Jiang
Journal:  AJNR Am J Neuroradiol       Date:  2011-02-24       Impact factor: 3.825

Review 3.  The mitochondrial myopathy encephalopathy, lactic acidosis with stroke-like episodes (MELAS) syndrome: a review of treatment options.

Authors:  Fernando Scaglia; Jennifer L Northrop
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

Review 4.  Citrulline and arginine utility in treating nitric oxide deficiency in mitochondrial disorders.

Authors:  Ayman W El-Hattab; Lisa T Emrick; William J Craigen; Fernando Scaglia
Journal:  Mol Genet Metab       Date:  2012-07-06       Impact factor: 4.797

5.  Mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive clinical syndrome.

Authors:  S G Pavlakis; P C Phillips; S DiMauro; D C De Vivo; L P Rowland
Journal:  Ann Neurol       Date:  1984-10       Impact factor: 10.422

6.  Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome.

Authors:  T Iizuka; F Sakai; N Suzuki; T Hata; S Tsukahara; M Fukuda; Y Takiyama
Journal:  Neurology       Date:  2002-09-24       Impact factor: 9.910

Review 7.  Mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes: an important cause of stroke in young people.

Authors:  John Aaron Goodfellow; Krishna Dani; Willie Stewart; Celestine Santosh; John McLean; Sharon Mulhern; Saif Razvi
Journal:  Postgrad Med J       Date:  2012-02-10       Impact factor: 2.401

8.  MELAS syndrome: imaging and proton MR spectroscopic findings.

Authors:  M Castillo; L Kwock; C Green
Journal:  AJNR Am J Neuroradiol       Date:  1995-02       Impact factor: 3.825

  8 in total
  3 in total

1.  l-Arginine in Mitochondrial Encephalopathy, Lactic Acidosis, and Stroke-like Episodes: A Systematic Review.

Authors:  Renae J Stefanetti; Yi Shiau Ng; Linda Errington; Alasdair P Blain; Robert McFarland; Gráinne S Gorman
Journal:  Neurology       Date:  2022-04-15       Impact factor: 11.800

2.  MELAS Syndrome with Cardiac Involvement: A Multimodality Imaging Approach.

Authors:  Sara Seitun; Laura Massobrio; Anna Rubegni; Claudia Nesti; Margherita Castiglione Morelli; Sara Boccalini; Athena Galletto Pregliasco; Irilda Budaj; Luca Deferrari; Gian Marco Rosa; Fabrizio Montecucco; Alberto Valbusa
Journal:  Case Rep Cardiol       Date:  2016-11-07

3.  A Mitochondrial Disorder in a Middle Age Iranian Patient: Report of a Rare Case.

Authors:  Mostafa Almasi; Mohammad Reza Motamed; Masoud Mehrpour; Bahram Haghi-Ashtiani; Fahimeh Haji Akhondi; Yalda Nilipour; Seyed-Mohammad Fereshtehnejad
Journal:  Basic Clin Neurosci       Date:  2017 Jul-Aug
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.